Metabolic and cardiovascular benefits of GLP1 agonists, besides the hypoglycemic effect
If you struggle to incorporate veggies into your diet, try to find ways you can add them to the meals that you already love
Kawatani, M., Itoi, K., Talukder, A
Market and Regulatory Pressure: Where the System Is Moving The rapid expansion of GLP-1 therapies has placed them at the center of market competition, regulatory scrutiny, and policy debate
Results: Statin use was associated with significantly lower risk of portal hypertension (OR 0.83, 95% CI 0.80-0.85), SBP (OR 0.52, 95% CI 0.39-0.67), thrombosis (OR 0.69, 95% CI 0.64-0.76), HE (OR 0.7, 95% CI 0.68-0.74) and HRS (OR 0.61, 95% CI 0.52-0.72)
Reduces Risk of Dehydration : Appetite suppression, vomiting, and diarrhea can quickly deplete your fluid levels